成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart 0 Sign in  

[ CAS No. 557756-85-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 557756-85-1
Chemical Structure| 557756-85-1
Structure of 557756-85-1 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 557756-85-1 ]

Related Doc. of [ 557756-85-1 ]

Alternatived Products of [ 557756-85-1 ]
Product Citations

Product Citations

Ajay Kumar Sharma ; Kuldeep Gupta ; Akhilesh Mishra , et al. DOI:

Abstract: The limited availability of molecularly targeted low-molecular-weight imaging agents for monitoring multiple myeloma (MM)-targeted therapies has been a significant challenge in the field. In response, a first-in-class peptide-based radiotracer, [68Ga]Ga-AJ206, is developed that can be seamlessly integrated into the standard clinical workflow and is specifically designed to noninvasively quantify levels and pharmacodynamics by positron emission tomography (PET). A bicyclic , AJ206, is synthesized and exhibits high affinity to (KD: 19.1 ± 0.99 × 10?9 m) by surface plasmon resonance. Further, [68Ga]Ga-AJ206-PET shows high contrast within 60 min and suitable absorbed dose estimates for clinical use. Additionally, [68Ga]Ga-AJ206 detects expression in cell line-derived xenografts, patient-derived xenografts (PDXs), and disseminated disease models in a manner consistent with flow cytometry and immunohistochemistry findings. Moreover, [68Ga]Ga-AJ206-PET successfully quantifies pharmacodynamics in PDXs, revealing increased expression in the tumor following all-trans (ATRA) therapy. In conclusion, [68Ga]Ga-AJ206 exhibits the salient features required for clinical translation, providing CD38-specific high-contrast images in multiple models of MM. [68Ga]Ga-AJ206-PET could be useful for quantifying total levels and pharmacodynamics during therapy to evaluate approved and new therapies in MM and other diseases with involvement.

Purchased from AmBeed: ;

Product Details of [ 557756-85-1 ]

CAS No. :557756-85-1 MDL No. :MFCD06656472
Formula : C26H33NO8 Boiling Point : -
Linear Structure Formula :- InChI Key :NUHRPLKTAAVHCZ-UHFFFAOYSA-N
M.W : 487.54 Pubchem ID :2756186
Synonyms :
Chemical Name :1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16-pentaoxa-4-azanonadecan-19-oic acid

Calculated chemistry of [ 557756-85-1 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 35
Num. arom. heavy atoms : 12
Fraction Csp3 : 0.46
Num. rotatable bonds : 19
Num. H-bond acceptors : 8.0
Num. H-bond donors : 2.0
Molar Refractivity : 127.97
TPSA : 112.55 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : Yes
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : Yes
Log Kp (skin permeation) : -7.88 cm/s

Lipophilicity

Log Po/w (iLOGP) : 3.78
Log Po/w (XLOGP3) : 1.97
Log Po/w (WLOGP) : 3.07
Log Po/w (MLOGP) : 0.88
Log Po/w (SILICOS-IT) : 4.17
Consensus Log Po/w : 2.77

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 1.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -3.1
Solubility : 0.384 mg/ml ; 0.000788 mol/l
Class : Soluble
Log S (Ali) : -3.96
Solubility : 0.0536 mg/ml ; 0.00011 mol/l
Class : Soluble
Log S (SILICOS-IT) : -7.32
Solubility : 0.0000233 mg/ml ; 0.0000000478 mol/l
Class : Poorly soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 2.0
Synthetic accessibility : 4.65

Safety of [ 557756-85-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Related Functional Groups of
[ 557756-85-1 ]

Ethers

Chemical Structure| 882847-32-7

[ 882847-32-7 ]

1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16,19-hexaoxa-4-azadocosan-22-oic acid

Similarity: 1.00

Chemical Structure| 867062-95-1

[ 867062-95-1 ]

1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13-tetraoxa-4-azahexadecan-16-oic acid

Similarity: 1.00

Chemical Structure| 872679-70-4

[ 872679-70-4 ]

1-(9H-Fluoren-9-yl)-3-oxo-2,7,10-trioxa-4-azatridecan-13-oic acid

Similarity: 0.97

Chemical Structure| 139338-72-0

[ 139338-72-0 ]

1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13-tetraoxa-4-azapentadecan-15-oic acid

Similarity: 0.89

Chemical Structure| 260367-12-2

[ 260367-12-2 ]

2-(2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)ethoxy)acetic acid

Similarity: 0.89

Amides

Chemical Structure| 882847-32-7

[ 882847-32-7 ]

1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16,19-hexaoxa-4-azadocosan-22-oic acid

Similarity: 1.00

Chemical Structure| 867062-95-1

[ 867062-95-1 ]

1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13-tetraoxa-4-azahexadecan-16-oic acid

Similarity: 1.00

Chemical Structure| 872679-70-4

[ 872679-70-4 ]

1-(9H-Fluoren-9-yl)-3-oxo-2,7,10-trioxa-4-azatridecan-13-oic acid

Similarity: 0.97

Chemical Structure| 139338-72-0

[ 139338-72-0 ]

1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13-tetraoxa-4-azapentadecan-15-oic acid

Similarity: 0.89

Chemical Structure| 260367-12-2

[ 260367-12-2 ]

2-(2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)ethoxy)acetic acid

Similarity: 0.89

Amines

Chemical Structure| 882847-32-7

[ 882847-32-7 ]

1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16,19-hexaoxa-4-azadocosan-22-oic acid

Similarity: 1.00

Chemical Structure| 867062-95-1

[ 867062-95-1 ]

1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13-tetraoxa-4-azahexadecan-16-oic acid

Similarity: 1.00

Chemical Structure| 872679-70-4

[ 872679-70-4 ]

1-(9H-Fluoren-9-yl)-3-oxo-2,7,10-trioxa-4-azatridecan-13-oic acid

Similarity: 0.97

Chemical Structure| 139338-72-0

[ 139338-72-0 ]

1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13-tetraoxa-4-azapentadecan-15-oic acid

Similarity: 0.89

Chemical Structure| 260367-12-2

[ 260367-12-2 ]

2-(2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)ethoxy)acetic acid

Similarity: 0.89

Carboxylic Acids

Chemical Structure| 882847-32-7

[ 882847-32-7 ]

1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16,19-hexaoxa-4-azadocosan-22-oic acid

Similarity: 1.00

Chemical Structure| 867062-95-1

[ 867062-95-1 ]

1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13-tetraoxa-4-azahexadecan-16-oic acid

Similarity: 1.00

Chemical Structure| 872679-70-4

[ 872679-70-4 ]

1-(9H-Fluoren-9-yl)-3-oxo-2,7,10-trioxa-4-azatridecan-13-oic acid

Similarity: 0.97

Chemical Structure| 139338-72-0

[ 139338-72-0 ]

1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13-tetraoxa-4-azapentadecan-15-oic acid

Similarity: 0.89

Chemical Structure| 260367-12-2

[ 260367-12-2 ]

2-(2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)ethoxy)acetic acid

Similarity: 0.89

; ;